You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康-B(06606.HK)擬先舊後新配售2754.3萬股 總籌7.82億港元
格隆匯 01-18 08:25

格隆匯1月18日丨諾輝健康-B(06606.HK)發佈公吿,2023年1月18日(聯交所交易時段前),認購人、公司及配售代理(即高盛與摩根大通)訂立配售及認購協議,據此各配售代理(基於各自而非共同或共同及各自基準)已同意作為認購人的代理進行配售(未能則自行購買),而認購人已同意出售合共2754.3萬股現有配售股份予不少於六名承配人,配售價為每股配售股份28.38港元;及認購人已有條件同意按每股認購股份28.38港元的認購價認購2754.3萬股新認購股份。

配售股份合共佔該公吿日期已發行股本約6.41%及因認購以及因認購而配發及發行認購股份經擴大的已發行股本約6.02%。預計認購所得款項總額及所得款項淨額將分別約為7.817億港元及7.751億港元。認購所得款項淨額預期將於五年內悉數動用,並將用於以下用途:(i)30%用於集團管線產品的進一步開發及商業化,包括但不限於CerviClear、 LiverClear及泛癌早期檢測管線項目以及集團的其他管線項目;(ii)40%用於集團的經營活動,包括但不限於投資設施及生產線,以擴大集團的經營能力及投資辦公樓,以容納集團的後勤部門;及(iii)30%用於集團的業務發展活動及投資,包括但不限於集團通過任何現有或未來專注於診斷及生命科學及工具的醫療行業特定風險投資基金進行的投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account